ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

SHARON SCOFIELD MARQUES MD

At A Glance: This Prescriber in 2012

We aren’t showing our typical comparisons because the provider updated his/her primary specialty after we conducted our analysis. The updated address appears on this page.

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,791Medicare Part D Prescriptions Filled, Including Refills
$534K Total Retail Price of All Prescriptions
705 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
28% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
SIMVASTATIN 380 333
LEVOTHYROXINE SODIUM 368 326
AMLODIPINE BESYLATE 285 252
PRAVASTATIN SODIUM 270 225
LISINOPRIL 258 233
METOPROLOL TARTRATE 248 208
OMEPRAZOLE 214 183
HYDROCODONE-ACETAMINOPHEN 206 124 S3
HYDROCHLOROTHIAZIDE 188 156
METFORMIN HCL 170 149
ATENOLOL 164 137
CITALOPRAM HBR 137 125
LOSARTAN POTASSIUM 132 122
OXYCODONE HCL 122 90 S2
ENALAPRIL MALEATE 115 108
FENOFIBRATE 111 93
CARVEDILOL 109 104
FUROSEMIDE 107 102
METOPROLOL SUCCINATE 106 88
GABAPENTIN 105 65
MORPHINE SULFATE ER 100 59 S2
ALENDRONATE SODIUM 97 86
TRAMADOL HCL 94 72
GLIMEPIRIDE 92 70
ALPRAZOLAM 90 62
ZOLPIDEM TARTRATE 84 53
FLUOXETINE HCL 83 67
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 74
ATORVASTATIN CALCIUM 81 80
FLUTICASONE PROPIONATE 79 63
ALLOPURINOL 75 57
GLIPIZIDE 74 72
LOVASTATIN 74 68
TRAZODONE HCL 73 57
WARFARIN SODIUM 67 50
POTASSIUM CHLORIDE 65 59
PAROXETINE HCL 63 51
PREDNISONE 63 39
SERTRALINE HCL 60 57
PANTOPRAZOLE SODIUM 58 40
SYNTHROID 51 43
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 18, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.